Nearly a third of medical device adverse events were not submitted to the FDA within a 30-day regulatory window, with most ...
The U.S. stock market’s woes continued for the fourth consecutive week, with major indices closing in red amid trade and ...
Abbott Laboratories' medical device business is executing well, with double-digit growth in structural heart and diabetes.
Discover last week's top S&P 500 healthcare gainers, major market stories, and groundbreaking pharma deals, including weight-loss drug updates.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback